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Femoral and radial artery access continue to be the standard of care for percutaneous
coronary interventions. Cardiac catheterization has progressed to encompass a wide
range of diagnostic and interventional procedures including coronary, peripheral,
endovascular, and structural heart disease interventions. Despite advanced technol-
ogy to make these procedures safe, bleeding, and vascular complications continue to
be a substantial source of morbidity, especially in patients undergoing large-bore
access procedures. New variations of percutaneous devices have reduced complica-
tions associated with these procedures. However, safe vascular access with effective
hemostasis requires special techniques which have not been well described in the
literature. Large-bore femoral artery access is feasible, safe, and associated with low
complication rates when a protocol is implemented. Wayne State University, Detroit
Medical Center Heart Hospital is a tertiary care, high-volume center for endovascular,
structural heart and complex high risk indicated procedureswithmore 150 procedures
involvingmechanical circulatory support (MCS) devices per year. In thismanuscript, we
describe our approach to femoral artery large-bore sheath insertion and management.
Our protocol includes proper identification of the puncture site, device selection,
insertion, assessment of limb perfusionwhile on prolongMCS support, and hemostasis
techniques after sheath removal.
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1 | INTRODUCTION
Successful cardiac catheterization beginswith safe vascular access and
endswith effective hemostasis after equipment removal. Over the past
years, cardiac catheterization has progressed to encompass a wide
range of diagnostic and interventional procedures including coronary,
peripheral, endovascular, and structural heart disease interventions.
Vascular access has evolved from an approach requiring surgical
cutdown in the 1940's with primitive catheters to current percutane-
ous techniques using advanced catheters, guides, wires, and closure
devices that allow safe arteriotomy and effective closure.1–3
Despite multiple adjustments in devices and techniques, bleeding,
and vascular complications continue to be a substantial source of
Abbreviations: CHIP, complex high risk indicated patients; EVAR, endovascular aortic
repair; MCS, mechanical circulatory support; TAVR, transcatheter aortic valve replacement.
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morbidity especially in patients undergoing large-bore access proce-
dures.4–6 Although femoral access is themost common approach in the
United States, adoption of transradial access has been increasing.7–9
Over the years, elderly patients with multiple comorbidities are
increasingly referred for high risk structural and endovascular
interventions that often require mechanical circulatory support
(MCS). These new and advanced technologies require large-bore
arterial accesses.10,11
This article will address large-bore sheath insertion, maintenance,
and removal. Techniques for the maintenance of lower limb perfusion
during large-bore sheath access and the management of vascular
complications will also be discussed in detail.
1.1 | Impact of peripheral vascular disease on
vascular access
The size of the iliac and common femoral arteries varies greatly,
depending mainly on the patient body habitus and may be affected by
the extent of atherosclerosis and tortuosity.12,13 Peripheral vascular
disease (PVD) and coronary artery disease (CAD) have similar risk
factors, and thus, it is common to encounter the challenge of treating
structural or complex high-risk indicated patients (CHIP) with
concomitant significant PVD.14,15 Small caliber common femoral and
iliac arteries (less than 5.5 mm) with significant PVD increase the risk
for vascular complications. The risk increases even more when larger
bore sheaths are used.6,16–18 In some patients, femoral vascular access
is prohibitive or carries extreme risk due to small caliber, complete
occlusion, or severe calcification. This is often discovered at the time of
procedure as patient presenting with acute coronary syndrome or
cardiogenic shock that requires immediate attention and access for
mechanical support. In these cases, alternative arterial access sites
such as axillary artery, carotid artery, subclavian artery, transcaval, and
direct transapical approaches.19–24
1.2 | Mechanical circulatory support (MCS) devices
Temporary percutaneous MCS devices are indicated for patients
presentingwith cardiogenic shock and thosewho are undergoing high-
risk coronary interventions. Based on the amount of hemodynamic
support required, operators have different percutaneous MCS devices
which provide adequate circulatory support during high risk proce-
dures. Venoarterial extracorporeal membrane oxygenation (VA-
ECMO) and TandemHeart (centrifugal-flow pump, TandemLife,
Pittsburgh, PA) are available in the United States. Both devices require
two large-bore cannulas, one inserted into the vein (and into the left
atrium via transseptal puncture for TandemHeart) and another into the
artery. ECMO and TandemHeart devices require an arterial cannula
ranging between 15-20 Fr. MCS that requires arterial access only
include PulseCath and Impella. PulseCath uses an intra-aortic balloon
pump console and requires a 19 Fr sheath. This device provides
approximately 2 L/min flow. The Impella 2.5 and CP devices (Abiomed
Inc., Danvers, MA) are FDA-approved for up to 6 days for cardiogenic
shock and up to 6 h for high risk coronary interventions. The Impella
2.5 and CP provide direct cardiac unloading and antegrade flow of up
to 2.5 and 4.0 L/min, respectively. These two devices require a single
arterial access of 13 Fr and 14 Fr, respectively.
1.3 | Access site selection
For advanced interventional procedures, multiple access sites are
often needed. In these scenarios, a combination of transradial and
femoral approach is utilized.Whereby the transradial approach is used
to perform coronary interventions and the femoral artery is used to
deploy a temporary percutaneous MCS device or perform structural
interventions. In patients who are scheduled for such advanced
procedures, the anatomy of at least one of the ilio-femoral arteries is
known from previous procedures or previous CT studies or iliofemoral
arteries. This allows the operator to plan the optimal arteriotomy site
prior to the procedure by selecting access site and proper sheath size.
An ultrasound-guided arterial puncture technique is recommended to
ensure good visualization of the arterial puncture site. This may be
achieved with fluoroscopy or ultrasound. The fluoroscopy-guided
technique is the most frequently used. This technique initially calls for
palpation of anatomic landmarks and pulse. Then, a radiopaque object
is placed at the body surface and used as a reference to identify the
location of the femoral head landmarks.11,25,26 Ultrasound-guided
access can be used to improve arterial puncture safely by appropriately
targeting the puncture at the level of the common femoral artery (CFA)
and thereby avoiding puncture of the profunda, the superficial femoral
arteries and disruption of a heavily calcified area. Seto et al27 showed
that routine real-time ultrasound guidance improved CFA cannulation
only in patients with high CFA bifurcations but reduced the number of
attempts, time to access, risk of venipunctures, and vascular
complications in femoral arterial access. Hind et al28 suggested that
ultrasound guidance access results in more precise CFA anterior wall
puncture and may result in fewer post-therapy complications when
compared to fluoroscopy.
After the first arterial access is established, performing angiogra-
phy of the iliac bifurcation with right and/or left iliac arteries to define
the access site and vessels anatomy is recommended (Figure 1). This
approach is also used to define the anatomy of the contralateral vessel
using 10mL of contrast media injected from contralateral side using 5
or 6-French IMA catheter and eventually the artery away from
calcification and in the middle third of the femoral head. It is important
to study the vessel size, degree of vessel tortuosity as well as
calcification. Favorable features include iliac arteries diameter of
5.5mm or more with minimal tortuosity and/or atherosclerosis.
Alternatively, an iliac diameter of less than 5mm with high tortuosity
and significant atherosclerosis may preclude from using the vessel for
large-bore (>10-French) sheath access. Although rarely used at our
institution, intravascular ultrasound (IVUS) may provide excellent
assessment of the vessel anatomy including a detailed view of a
diseased artery, including vessel size, plaque volume, calcification, and
tortuosity and has an added value of reducing the need for contrast.
Planning access for TAVR requires knowledge of the luminal size as
well as the degree of vessel calcification and tortuosity. Ramlawi et al29
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consider a high-quality thin-slice CT scan with contrast that extends
from the femoral artery to the subclavian artery the cornerstone of
evaluation. Also, CT angiography of the iliofemoral vasculature enables
evaluation of vessel tortuosity, calcifications, and vessel diameters and
may thereby inform decisions on the most suitable interventional
approach.
1.4 | Femoral artery large size sheath insertion
techniques
Using ultrasound or direct fluoroscopy technique, a micropuncture
needle is used to access the CFA. 6-French sheath then advanced over
the micropuncture wire. Through the 6-French sheath, a stiff 0.035
wire (Supra Core or Lunderquist) wire is advanced and two Perclose
ProGlide suture-mediated closure systems are deployed at 10′ and 2′
o’clock position. This facilitates future successful closure of the large-
bore puncture site.30,31 Subsequently, a sequential upsizing of the
arterial puncture is performedwith a series of dilators over a stiff 0.035
wire, prior to placement of the large sheath.
1.5 | Maintaining lower extremity perfusion
After the large-bore sheath is positioned and secured, it is crucial to
assess vessel patency and assure preserved distal perfusion into the
extremity (Figure 2). An aorto-iliac angiogram is performed by contrast
injection through the large-bore sheath's side arm or by using selective
catheter engagement into the ipsilateral iliac artery from an additional
arterial access. The extremities are able to tolerate low perfusion state
for short periods of time (less than 30min).32 However, when limb
perfusion is compromised it may be necessary to establish flow distally
by ex-vivo ipsilateral bypass using antegrade access technique.
For patients presented to the cath lab with cardiogenic shock or
electivehigh-risk coronary intervention, Impella 2.5 orCPhavebeen the
device of choice in the US. Impella 2.5 and CP provide direct cardiac
pressure and volume unloading of the left ventricle and antegrade flow
in the thoracic aorta of up to 2.5 and 4.0 L/min, respectively. The
catheter-based device is typically inserted through a peripheral access
using a single arterial access of 13 Fr and 14 Fr, respectively. Impella has
a specially designed two-steppeel away sheathwith a tapered shaft (14-
Frenchbase to 9-French tip) that allows for adequate blood floweven in
smaller caliber ilio-femoral arterial vessels. Once Impella device is
positioned in place, the peel-away sheath then removed and
repositioning sheath is advanced to the access site.
1.6 | Reperfusion techniques
PVD and CAD have similar risk factors, and thus, it is common to
encounter the challenge of treating structural or complex coronary
patients with significant concomitant PAD.14,15,33 Small caliber
common femoral and iliac arteries with severe PAD significantly
increase the risk for vascular complications. That risk increases greatly
as the larger bore sheaths are used.6,16–18
FIGURE 1 4 Fr left common femoral arterial access using
micropuncture (green arrow). Notice the access point relation with
the femoral head (asterisk). Left iliac-femoral angiography with no
signs of atherosclerosis or stenosis
FIGURE 2 Right ilio-femoral angiogram with Impella 14 Fr sheath
(green arrow) showing adequate flow into the superficial femoral
artery and deep femoral arteries (orange arrows) around the large-
bore sheath
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Insertion of large bore sheath may result in complete vessel
occlusion and acute limb ischemia that may threaten limb viability. It is
therefore important to ensure adequate perfusion to the limb by
careful assessment of the iliofemoral artery prior to insertion of large
bore sheath. A challenging clinical scenario often encountered in
practice is a patient who is hemodynamically dependent on a short-
term mechanical support device and whose large bore sheath is found
to be occlusive. Several interventions can be performed in the setting
of an occlusive sheath to restore perfusion to the distal lower
extremity in such patients.
1.6.1 | Peel away sheath
The Impella mechanical support device comes with a specially
designed 2-step peel away sheath with a tapered shaft (14 Fr base
to 9 Fr tip) that allows for adequate blood flow even in smaller caliber
ilio-femoral arterial vessels. In case of an occlusive sheath compromis-
ing limb perfusion, peeling away the 14 Fr introducer sheath leaves the
Impella with the smaller 9 Fr repositioning sheath which may be
sufficient to restore limb perfusion. One potential complication of this
technique is catheter migration. To minimize this complication, two
people should carry out this intervention under direct fluoroscopic
guidance. Specifically, one operator stabilizes the Impella to avoid any
pullback while the other operator peels away the external sheath. The
repositioning sheath can then be re-advanced through the arteriotomy
site. This maneuver, however, may lead to increased bleeding as the
sheath size is tapered down.
1.6.2 | External contralateral bypass circuit
If there is occlusion of the external iliac artery and CFA by the large
bore sheath, the ipsilateral superficial femoral artery is accessed via a 4
or 5 Fr short sheath with a micro puncture kit in antegrade fashion. A
contralateral CFA access is then obtained with a 6 Fr sheath. Then the
side arm of the contralateral sheath is connected to the side arm of the
ipsilateral antegrade sheath using amale-to-male connector. The result
is an external femoral-femoral bypass whereby blood flows from the
contralateral 6 Fr sheath through the side arm into the side arm of the
ipsilateral 5 Fr antegrade sheath down the ischemic limb providing
adequate perfusion (Figures 3A and 3B). In situation when occlusion of
flow is anticipated (ie, ECMO sheath), antegrade access with 5 or 6 Fr
sheath can be placed preemptively prior to the large bore sheath
insertion. The target activated clotting time (ACT) should be higher
than standard to maintain the flow (range 200-220 s). Also, hourly
serial Doppler ultrasound assessment of the lower extremity
pulsations is recommended
1.6.3 | External ipsilateral bypass circuit
An alternative strategy utilizes the sidearm of the large bore occlusive
sheath to create an ipsilateral bypass circuit. A 4 to 5 Fr short sheath is
inserted in the ipsilateral superficial femoral artery with a micro
puncture kit in antegrade fashion. The side arm of the ipsilateral
antegrade sheath can then be connected via a male-to-male connector
to the side arm of the large bore occlusive sheath constituting an
ipsilateral bypass circuit that provides adequate perfusion to the lower
limb.When using this strategywith an Impella device, the repositioning
sheath must not be advanced into the Impella 14-Fr sheath to avoid
occlusion of the side arm that is now providing perfusion
(Figures 4A and 4B). The management of this conduit follows the
same protocol as that outlined above for the contralateral bypass
technique. The advantage of this strategy is that it does not require a
contralateral arterial access.
1.6.4 | Internal contralateral bypass circuit
The superficial femoral artery may be diseased and totally occluded,
not an uncommon finding in patients with CAD, precluding antegrade
superficial femoral artery access. In such cases, internal contralateral
femoral to profunda bypass might be an alternative option to maintain
perfusion to the ischemic limb. This is achieved by first inserting a 7 Fr
sheath in the contralateral CFA. Through this sheath, a 5 Fr catheter
(IMA, OMNI flush) is advanced and selectively engaged into the
ipsilateral common iliac artery. A 0.035 hydrophilic wire
FIGURE 3 A, Contralateral bypass circuit showing the side arm of
the contralateral common femoral artery sheath connected to the
side arm of the ipsilateral antegrade sheath via long extension
tubing and a male-to-male connector providing perfusion to the
superficial femoral artery. B, Figure depicting the contralateral
bypass circuit. Large occlusive sheath in the right common femoral
artery. Blood flows through the left 7 Fr sheath (green) to the 4 Fr
daughter sheath (yellow) and through the 45 cm catheter to the
contralateral side. The catheter then passes along the 14 Fr sheath
(blue) and to the right SFA
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(Terumo Glidewire® guidewire) is then advanced through this system
across the aorto-iliac bifurcation, past the occlusive large bore sheath
and beyond the arteriotomy site into the ipsilateral profunda femoris
artery in case of SFA occlusion. The 5 Fr catheter is then exchanged for
a 4 Fr, 45-55 cm long sheath that is advanced over the wire into the
ipsilateral profunda femoris. By connecting the side arm of the 7 Fr
contralateral sheath and that of the 4 Fr, 45-55 cm sheath using a
male-to-male connector, a bypass circuit is created whereby blood
flows from the contralateral femoral artery via the connected side
arms, through the cross-over 4 Fr sheath into the ipsilateral profunda
femoris artery distal to the occlusive sheath providing sufficient
perfusion to maintain limb viability (Figures 5 and 6). The management
of this conduit follows the same protocol as that outlined above for the
contralateral and the ipsilateral bypass techniques with anticoagula-
tion for a target ACT range of 200-220 s.
1.7 | Sheath removal and hemostasis
Hemostasis after removal of small arterial sheaths is often achieved
with manual compression, or with arterial closure devices that are
readily available. Larger sheaths have been associated with worse
outcome due to bleeding and vascular complications.6 Removal of
large-bore sheaths requires meticulous technique to prevent major or
even life-threatening bleeding complications and to assure vessel
patency. Manual compression of large arteriotomy is not the ideal
technique due to lack of direct visualization and poor control of the
puncture site. To date, there are no FDA-approved closure devices
designed for large size arterial punctures. Perclose ProGlide system
(Abbott Vascular Devices, CA) is a suture-mediated closure device
designed to close 5-8 French access sites.30,31 It is possible to usemore
than one suture and to pre-deploy the suture before upsizing to a
large-bore sheath as described above. Complete deployment of the
Perclose sutures is performed when the large-bore sheath is removed.
It is recommended to perform large-bore sheath removal in the cardiac
catheterization laboratory which provides best controlled environ-
ment. While in the cath lab, one operator can apply manual pressure
above the access point and pull the large sheath, while the second
operator deploying the closure device. In certain cases when the risk of
bleeding is high (anticoagulation, calcified vessel), we recommend dry
closure technique. Dry closure is achieved by advancing 6-9 × 40mm
peripheral balloon proximal to the access site. Once the balloon is
inflated the sheath then removed and PerClose device is deployed fully
and sutures snitched to the arteriotomy site.30,31
1.7.1 | Vascular closure device
Increased use of large-bore sheaths for structural heart procedures
and advanced MCS devices introduced the practice of preclosure with
Perclose VCD. Preclosure is done with partial deployment of suture-
mediated VCD after the artery is accessed with a small caliber sheath
and before insertion of the large-bore arterial sheath. Once the
procedure is done, preclosure will facilitate hemostasis once the large-
bore sheath is removed. Observational data demonstrated that
percutaneous approach to TAVR using VCD with preclosure is
associated with similar vascular outcomes to surgical cut-down for
arterial access, but with shorter length of stay.34–36 Routine use of
VCD for large bore access might reduce bleeding and vascular
complications, and facilitate patient ambulation and decrease hospital
FIGURE 4 A, Ipsilateral bypass circuit showing the side arm of
the large bore sheath connected to the side arm of the antegrade
sheath via a male-to-male connector providing distal perfusion. B,
Figure depicting another technique for ipsilateral bypass circuit.
Distal to the Impella sheath a 5 Fr sheath was used to access the
ipsilateral common femoral artery. The side arm of the Impella and
5 Fr sheath are connected using male-to-male connector creating a
continuous flow from Impella sheath (blue) to the side arm of the
5 Fr sheath located in the SFA (green)
FIGURE 5 Internal contralateral femoral to ipsilateral profunda
femoris bypass circuit showing the side arm of the contralateral
(Right) 7 Fr femoral sheath connected to the side arm of the 4 Fr
45–55 cm cross-over sheath via a male-to-male connector providing
perfusion to the ipsilateral (Left) profunda femoris artery distal to
the occlusive (Left) large sheath
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length of stay. Despite increasing experience with VCD, complications
of VCD include infection, embolization, and device failure leading to
ischemia or access-site bleeding. VCD-related complications increase
with lack of proficiency with the selected device.37 Several new large
caliber VCD are in development for structural heart interventions, and
are undergoing clinical investigation.38
For patients treated with Impella and require delayed hemostasis,
the closure system needs to be sterilized, and secured especially if
MCS is indicated for several days. Our practice is to sterilize the
Perclose sutures, snare knot pusher, and suture trimmer with
chlorhexidine gluconate (ChloraPrep®) and use Tegaderm to keep
them separate and away from the access site. We then re-sterilize the
site with ChloraPrep and wrap all Perclose parts with sterile towels.39
We keep the Perclose sutures under the Tegaderm for 2-3 days on
average. The duration depends on severity of current shock and time
to recovery.
1.7.2 | Temporary endovascular balloon tamponade
The temporary endovascular balloon tamponade or “dry field closure
technique,” is a useful technique that prevents extensive bleeding at
the time of large-bore access closure. It allows the operator to have
control of the access site while deploying VCD especially in patients
who are at increased risk for bleeding (ie, on anticoagulation, access
site calcification, vascular tortuosity). From a 7-French sheath in the
contralateral CFA, a 5Fr catheter (IMA, OMNI flush) is advanced and
selectively engaged into the ipsilateral common iliac artery. Then, a
0.035 hydrophilic stiff wire (TerumoGlideAdvantagewire) is advanced
into the ipsilateral CFA, where the large-bore sheath is inserted. The
wire is further advanced around the large sheath and distal to the
arteriotomy site into the superficial femoral artery. Afterwards, the
sheath and the catheter are exchanged into 45-55 cm long sheath. The
long sheath is then advanced to the level of the ipsilateral external iliac
artery. The large-bore sheath is withdrawn to the level of the distal
segment of the external iliac artery. Subsequently, an 8-9mm
diameter × 20-40mm long balloon (size of the balloon is determined
by femoral angiogram) is inflated to low pressure (2-4 ATM) to
temporarily occlude flow in the external iliac artery proximal to the
large-bore sheath. To monitor effective occlusion, a pressure
transducer is connected to the large-bore sheath side branch. With
effective balloon inflation, the pressure wave form flattens, and the
pulse pressure diminishes (Figure 7). The large-bore sheath is then
removed from the body and the partially deployed Perclose ProGlide
sutures seal the puncture site. Once this step is done, the occlusive
balloon tamponade slowly deflated to restore blood flow to the access
leg. If residual bleeding is present after Perclose ProGlide sutures
deployment, then same balloon is advanced at the arteriotomy and
inflated to provide endovascular low-pressure tamponade until
hemostasis is achieved. Protamine Sulfate can be used to reverse
anticoagulation when hemostasis is not achieved.
Dry field technique can be used in emergency situations when the
large-bore sheath is inserted quicklywithout Perclose ProGlide sutures
to expedite MCS support. When it is appropriate to remove the large-
bore sheath, prolonged endovascular balloon tamponade (30-60min)
may be sufficient to achieve hemostasis. Rarely, the arteriotomy site
may continue to bleed after this intervention. In that case, a covered
stent can be deployed at the arteriotomy site to achieve hemostasis.
FIGURE 6 Hemodynamic tracing of external iliac artery via Impella 14 Fr sheath side arm during endovascular temporary 40 × 9mm
balloon inflation. Tracing illustrates blunting of pulse pressure (blue arrow) that confirm adequate temporary internal occlusion of the common
femoral artery
FIGURE 7 Right iliac, right common femoral artery, and
bifurcation showing post procedure intact vessels with complete
hemostasis. The arrow indicates the access site
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Once hemostasis is achieved, the recommendation is to confirm vessel
patency and rule out sheath-related complications such as vessel
dissection, occlusion, thrombosis by performing a final angiogram
using a pigtail in the descending aorta or contralateral femoral catheter
(Figure 8). VIABAHN® (GORE®) is self-expandable covered stents are
indicated for iliac and superficial femoral artery complications. Six
millimeter diameter stents can be delivered via 6-French arterial
sheath while 7 and 8mm stents are requires 7-French arterial sheath.
iCast on the otherhand is a balloon-expandable stent that is available in
diameters of 5-12mm and delivered via 6 or 7-French introducer
sheath.
1.8 | Complication management
1.8.1 | Acute limb ischemia
Acute limb ischemia in the setting of large-bore access can be due to
complete vessel occlusion (when vessel diameter is <5.0mm), arterial
dissection or thromboembolism. Utilization of a femoral-femoral bypass
circuit, as described above, may prevent these complications. Close
monitoring to ensure adequate limb perfusion with hourly clinical and
Doppler assessment of distal extremity pulses is indicated when the
sheath is in place. Serial biomarker evaluation (plasma lactate) is
recommended as a surrogate for inadequate limb perfusion and tissue
necrosis. Thromboembolism or plaque embolization are not uncommon
complications.6 Thrombus or debris may flow downstream causing
occlusion of the tibio-peroneal trifurcation causing acute limb ischemia.
After sheath removal, it is recommended to perform complete
angiography of the arteriotomy site and runoff to the tibio-peroneal
trifurcation at the end of procedure to assure distal vessels patency.
1.8.2 | Vascular pseudoaneurysm
In a patient with a recent history of femoral artery puncture the presence
of pain, swelling, and a palpable mass in the groin should prompt further
investigation. The mass may be pulsatile with a thrill or bruit.
Complications can arise due to mass effect. Arteriotomy below the
CFAbifurcation is associatedwithan increased riskof local hematomaand
pseudoaneurysm formation owing to the lack of the posterior anchoring
of manual compression provided by the head of the femur. Other risk
factors for pseudoaneurysm include: multiple arterial punctures, and
large-bore sheath usage.40–42 Meticulous access technique as presented
should preclude from multiple arterial punctures and suboptimal access
location. Nevertheless, even with the best technique pseudoaneurysms
may still occur. Pseudoaneurysms are commonly diagnosed clinically and
confirmed with ultrasound imaging. The pseudoaneurysm can be treated
inmultipleways. To illustrate, themajorityof small pseudoaneurysms (less
than 2-3 cm) arising from arterial puncture are known to thrombose
spontaneously within 4 weeks and thus conservative management is
appropriate. A second option of treatment is percutaneous ultrasound-
guided thrombin injection into the pseudoaneurysm. Thrombin converts
fibrinogen into fibrin. Fibrin is then cross-linked by factor XIIIa in the
presenceof calcium leading to the formationof thrombus. The final option
is surgical repair. Rapid expansion, rupture, infection, and mass effect
resulting in distal or cutaneous ischaemia or peripheral neuropathy are
indications for surgery.43–45
1.8.3 | Bleeding
The femoral artery is a large-caliber vessel with diameter ranging from
8 to 9mm in normal adults which accommodate large sheaths.6,46 The
femoral artery enters the retroperitoneal space before joining the iliac
artery. If the arteriotomy site is too high, this may lead to a
retroperitoneal hematoma. This is a rare complication of femoral
artery access, but is associated with highmortality.47 It is imperative to
have high level of suspicion for these complications and develop a
protocol for prompt identification andmanagement. The first step is to
prevent ongoing extravasation. This is achieved by inflating a balloon
at low pressure to cover the site of perforation. While bleeding is
controlled, a covered stent is rapidly deployed. Simultaneously, a
vascular surgeon should be notified and made ready for possible
emergent transfer of the patient for emergency surgery in the event
percutaneous management of this complication fails.
2 | CONCLUSION
Arterial access and hemostasis are fundamental aspects of cardiac
catheterization and intervention. In recent years, large-bore sheaths
FIGURE 8 Digital subtraction angiography of the right SFA-
popliteal and trifurcation shows acute arterial thrombosis occluding
the right popliteal artery (arrow)
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for structural heart procedures and advanced MCS devices have been
used more frequently. Emerging approaches to arteriotomy, and new-
generation VCD have a role in reducing vascular complications and
bleeding associated with large-bore access procedure and accelerates
the time to hemostasis and ambulation.
CLINICAL PERSPECTIVES
Despite the increasing use large-bore femoral accesses, there are no
unified protocols to guide the large-bore femoral technique. This
article provides strategies for placement, removal, and complication
management to serve as a guide for interventional cardiologists who
use large-bore femoral arterial access and includes several techniques
that were developed over the last decade at our center with the
experience of thousands of large-bore femoral arterial procedures.
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